Assistant Professor of Medicine, Dana-Farber Cancer Institute
Oncology
Dr. Rachel A. Freedman, MD
|
|
Give Review
Rachel Freedman works in the field of Oncology. She went to Georgetown University School of Medicine. Georgetown University School of Medicine is ranked 49 in research and 84 in primary care medicine Rachel Freedman is also published. She has 20 publications published. The lastest publication: "Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.'
Publications
- Treatment of Breast Cancer in the Elderly.
- Racial/ethnic disparities in knowledge about one's breast Cancer characteristics.
- Patterns of chemotherapy, toxicity, and short-term outcomes for older women receiving adjuvant trastuzumab-based therapy.
- Duration and Toxicity of Adjuvant Trastuzumab in Older Patients With Early-Stage Breast Cancer: A Population-Based Study.
- A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast Cancer brain metastases.
- Management of breast Cancer in very young women.
- Cognitive function in older women with breast Cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907.
- Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast Cancer by race/ethnicity and education within the National Co...
- Trends in co-prescribing of antidepressants and tamoxifen among women with breast Cancer, 2004-2010.
- Treatment of Breast Cancer Brain Metastases.
- Reply to receipt of adjuvant breast Cancer therapy in minority women.
- A Phase II Study of Sagopilone (ZK 219477; ZK-EPO) in Patients With Breast Cancer and Brain Metastases.
- Family Cancer history: healthy skepticism required.
- The association of race/ethnicity, insurance status, and socioeconomic factors with breast Cancer care.
- Trends in racial and age disparities in definitive local therapy of early-stage breast Cancer.
- Reducing disparities in breast Cancer care: a daunting but essential responsibility.
- Glioblastoma in a patient with early-stage tonsil Cancer.
- Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
- Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast C...
Schools
Georgetown University School Of Medicine
Beth Israel Deaconess Med Center
Dana Farber Cancer Institute
Conditions Treated
- Adrenal Gland Cancer
- Anemia
- Breast Cancer
- Carcinoma in Situ
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Brigham and Women's Hospital -
Beth Israel Deaconess Medical Center -
Georgetown University School of Medicine
Hospital
-
Brigham and Women's Hospital -
Massachusetts General Hospital -
Dana-Farber Cancer Institute
Helpful Reviews
Similar Doctors
|
|
Dr. Craig C. Earle, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Kerry E. Kilbridge, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David R. D'Adamo, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Stephen M. Rothenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Philip W. Kantoff, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Pankaj Bhargava, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rameen Beroukhim, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Richard A. Robinson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edwin Choy, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|